Journal of Gastrointestinal Cancer最新文献

筛选
英文 中文
Ketotifen for Preventing Oxaliplatin-Induced Neuropathy in Stage III Colorectal Cancer: a Randomized Controlled Trial. 酮替芬预防奥沙利铂诱导的III期结直肠癌神经病变:一项随机对照试验。
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2026-05-07 DOI: 10.1007/s12029-026-01456-4
Salma S Wahby, Tarek M Mostafa, Mohamed A Alm El-Din, Eman I Elberri
{"title":"Ketotifen for Preventing Oxaliplatin-Induced Neuropathy in Stage III Colorectal Cancer: a Randomized Controlled Trial.","authors":"Salma S Wahby, Tarek M Mostafa, Mohamed A Alm El-Din, Eman I Elberri","doi":"10.1007/s12029-026-01456-4","DOIUrl":"https://doi.org/10.1007/s12029-026-01456-4","url":null,"abstract":"<p><strong>Purpose: </strong>Oxaliplatin-induced peripheral neuropathy (OIPN) is a frequent, dose-limiting toxicity in colorectal cancer and markedly impairs quality of life. This study aimed to evaluate the protective role of ketotifen in preventing OIPN, considering its mast-cell stabilizing, histamine H1 receptor-blocking, anti-inflammatory, and analgesic properties demonstrated in preclinical models.</p><p><strong>Patients and methods: </strong>In this randomized controlled trial, 64 patients with stage III colorectal cancer were assigned to two groups. The control group (n = 32) received the standard mFOLFOX-6 regimen for 12 cycles, whereas the ketotifen group (n = 32) received the same regimen plus ketotifen 2 mg orally once daily. Neuropathy prevention was assessed through serum biomarkers (neurotensin, superoxide dismutase, interleukin-6), the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE v5.0), the 12-item neurotoxicity questionnaire (Ntx-12), and the Brief Pain Inventory-Short Form (BPI-SF).</p><p><strong>Results: </strong>After 12 cycles, the ketotifen group showed a significant reduction in interleukin-6 and neurotensin levels (p < 0.0001), a lower incidence of grade 2-3 neuropathy (p = 0.001), reduced pain severity (p < 0.0001), and better Ntx-12 scores (p < 0.0001) compared with controls. Ketotifen was well tolerated and improved quality of sleep and appetite (p < 0.0001), addressing additional patient-reported challenges.</p><p><strong>Conclusion: </strong>This trial indicates that ketotifen may offer a promising approach for preventing OIPN. Larger placebo-controlled, double-blind, multicenter trials are needed to confirm these findings.</p><p><strong>Clinicaltrial: </strong></p><p><strong>Gov identifier: </strong>NCT05624138.</p><p><strong>Trial registration date: </strong>1-11-2022.</p><p><strong>Clinical trial approval code: </strong>36030/11/22.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"57 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147838938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Replacing Multidisciplinary Team Meetings With Artificial Intelligence: Opportunities and Challenges". 评论“用人工智能取代多学科团队会议:机遇与挑战”
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2026-05-06 DOI: 10.1007/s12029-026-01477-z
Mohammed Razia Alangir Banu, Sumit Hazra, S Gousia Banu
{"title":"Comment on \"Replacing Multidisciplinary Team Meetings With Artificial Intelligence: Opportunities and Challenges\".","authors":"Mohammed Razia Alangir Banu, Sumit Hazra, S Gousia Banu","doi":"10.1007/s12029-026-01477-z","DOIUrl":"https://doi.org/10.1007/s12029-026-01477-z","url":null,"abstract":"","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"57 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147838859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementing RAPIDO Protocol for Total Neoadjuvant Treatment of Carcinoma Rectum: A Real Life Experience from a Tertiary Care Cancer Center in India. 实施RAPIDO方案全面新辅助治疗直肠癌:来自印度三级保健癌症中心的真实生活经验。
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2026-05-01 DOI: 10.1007/s12029-026-01476-0
Tapesh Bhattacharyya, Moses Arunsingh, Indranil Mallick, Salman Khurshid Shah, Amrit Pipara, Abhimanyu Kar, Arnab Bhattacharjee, Yusuf Malik, Sougata Maity
{"title":"Implementing RAPIDO Protocol for Total Neoadjuvant Treatment of Carcinoma Rectum: A Real Life Experience from a Tertiary Care Cancer Center in India.","authors":"Tapesh Bhattacharyya, Moses Arunsingh, Indranil Mallick, Salman Khurshid Shah, Amrit Pipara, Abhimanyu Kar, Arnab Bhattacharjee, Yusuf Malik, Sougata Maity","doi":"10.1007/s12029-026-01476-0","DOIUrl":"https://doi.org/10.1007/s12029-026-01476-0","url":null,"abstract":"<p><strong>Purpose: </strong>Total Neoadjuvant treatment (TNT) has now become the standard of care in locally advanced rectal cancer(LARC) and has shown promising results. However, use and outcome of different TNT regimens in real-world practice is largely unknown.Here we report the feasibility and efficacy of RAPIDO regimen which we adopted since 2021 for LARC.</p><p><strong>Materials and methods: </strong>A retrospective review of prospectively collected data, conducted at Tata Medical Center, Kolkata between January 2021 to June 2024. 95 consecutive patients with localized rectal adenocarcinoma, treated with short course radiotherapy 25 Gy/5frs/1week followed by CAPOX based chemotherapy with or without surgery were analysed. Data was collected in the Redcap Database.</p><p><strong>Results: </strong>The median age of the cohort was 53 years. Lower rectal disease, T4,N2,EMVI(Extramural Vascular Invasion) Grade 3/4, MRF (Mesorectal fascia) involvement were seen in 51(54%), 21(22.1%), 86(90.5%), 58(61%) and 70 (73.7%)patients respectively.62 patients (65.2%) underwent surgery. Pathological complete response (pCR) was achieved in 27.4%(17/62) cases. At a median follow-up of 2.4 years,43 patients (45.3%) underwent TNT and surgery and are disease free on follow up. Local failure was seen in 2 patients after surgery(3.2%)0.17 of 62 patients (27.4%) who underwent surgery developed distant metastasis with lung being the most common site (16.1%). The estimated 3 year overall survival of all patients was 83% and for patients who underwent surgery 3-year OS was 92% and 3-year disease free survival(DFS) was 63% Maximum grade≥ 3 diarrhoea and febrile neutropenia during chemotherapy were observed in 17 (17.9%) and 14 (14.7%) patients respectively.</p><p><strong>Conclusion: </strong>RAPIDO protocol in real world settings shows excellent response rates in LARC. It is a safe and feasible approach, however implementing a prolonged neoadjuvant treatment in the real world remains a challenge because of suboptimal compliance.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"57 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147816262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MET Amplification in Gallbladder Cancer: a Case Report on a Precision Medicine Approach with Glumetinib and Envafolimab. 胆囊癌MET扩增:格鲁替尼和恩伐利单抗联合应用精准医学的一例报告。
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2026-04-30 DOI: 10.1007/s12029-025-01384-9
Xiao-Jie Wu, Xi Nie, Jin-Fan Xu, Ren-Jie Gui, Hua-Xin Duan
{"title":"MET Amplification in Gallbladder Cancer: a Case Report on a Precision Medicine Approach with Glumetinib and Envafolimab.","authors":"Xiao-Jie Wu, Xi Nie, Jin-Fan Xu, Ren-Jie Gui, Hua-Xin Duan","doi":"10.1007/s12029-025-01384-9","DOIUrl":"10.1007/s12029-025-01384-9","url":null,"abstract":"","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"57 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13132897/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147773535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exclusive Neoadjuvant Chemotherapy with the FLOT Regimen Protocol in Resectable Gastric Cancer: A Retrospective Cohort Study in a Brazilian Reference Center. 可切除胃癌的独家新辅助化疗FLOT方案:巴西参考中心的回顾性队列研究。
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2026-04-27 DOI: 10.1007/s12029-026-01474-2
Kelre Wannlen Campos Silva Araújo, Fernanda Carneiro Ronchi, Carlos Eduardo Stecca, Carlos Roberto Naufel Júnior, Paulo Henrique Nocete, Rayssa Helena de Sena, Renata Medeiros Ferreira, Emily Karoline Araujo Nonato
{"title":"Exclusive Neoadjuvant Chemotherapy with the FLOT Regimen Protocol in Resectable Gastric Cancer: A Retrospective Cohort Study in a Brazilian Reference Center.","authors":"Kelre Wannlen Campos Silva Araújo, Fernanda Carneiro Ronchi, Carlos Eduardo Stecca, Carlos Roberto Naufel Júnior, Paulo Henrique Nocete, Rayssa Helena de Sena, Renata Medeiros Ferreira, Emily Karoline Araujo Nonato","doi":"10.1007/s12029-026-01474-2","DOIUrl":"https://doi.org/10.1007/s12029-026-01474-2","url":null,"abstract":"","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"57 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147773541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction Note: Impact of Obstructive Jaundice and Socioeconomic Determinants on Outcomes in Gallbladder Cancer: A Prospective Cohort Study. 撤回注:梗阻性黄疸和社会经济因素对胆囊癌预后的影响:一项前瞻性队列研究。
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2026-04-25 DOI: 10.1007/s12029-026-01475-1
Kumar Vineet, Mayank Tripathi, Dhaval R Vadodaria, Chandan Kumar, Divya Khanna
{"title":"Retraction Note: Impact of Obstructive Jaundice and Socioeconomic Determinants on Outcomes in Gallbladder Cancer: A Prospective Cohort Study.","authors":"Kumar Vineet, Mayank Tripathi, Dhaval R Vadodaria, Chandan Kumar, Divya Khanna","doi":"10.1007/s12029-026-01475-1","DOIUrl":"https://doi.org/10.1007/s12029-026-01475-1","url":null,"abstract":"","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"57 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147773491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CD74+tumour-Associated Macrophages Promote Immune Escape through Autonomous PD-L1 Eexpression in Gastric Cancer. CD74+肿瘤相关巨噬细胞通过自主表达PD-L1促进胃癌免疫逃逸
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2026-04-25 DOI: 10.1007/s12029-026-01470-6
Tianwei Xu, Anwei Xue, Yueda Chen, Chao Lin, Dansong Wang
{"title":"CD74<sup>+</sup>tumour-Associated Macrophages Promote Immune Escape through Autonomous PD-L1 Eexpression in Gastric Cancer.","authors":"Tianwei Xu, Anwei Xue, Yueda Chen, Chao Lin, Dansong Wang","doi":"10.1007/s12029-026-01470-6","DOIUrl":"https://doi.org/10.1007/s12029-026-01470-6","url":null,"abstract":"","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"57 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147773508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nonlinear Association Between Subcutaneous Fat Area and All-Cause Mortality in Postoperative Patients with Stage I-III Colorectal Cancer: A Multicenter Retrospective Study. 1 - 3期结直肠癌术后患者皮下脂肪面积与全因死亡率的非线性关系:一项多中心回顾性研究
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2026-04-24 DOI: 10.1007/s12029-026-01461-7
Duan Yang, Hongjiang Pu, Yan Man, Lizhu Liu, Peiyi Xie, XiaoYan Zhang, Shufeng Xiao
{"title":"Nonlinear Association Between Subcutaneous Fat Area and All-Cause Mortality in Postoperative Patients with Stage I-III Colorectal Cancer: A Multicenter Retrospective Study.","authors":"Duan Yang, Hongjiang Pu, Yan Man, Lizhu Liu, Peiyi Xie, XiaoYan Zhang, Shufeng Xiao","doi":"10.1007/s12029-026-01461-7","DOIUrl":"https://doi.org/10.1007/s12029-026-01461-7","url":null,"abstract":"","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"57 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147773518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiofrequency Ablation in the Treatment of Chronic Radiation Enteritis. 射频消融术治疗慢性放射性肠炎。
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2026-04-22 DOI: 10.1007/s12029-026-01458-2
Ming Chen, Xinguang Huang, Dongyang Wang, Huizhuan Zhai, Mingjuan Sun, Hao Zhang, Haipeng Wang, Zengjun Li
{"title":"Radiofrequency Ablation in the Treatment of Chronic Radiation Enteritis.","authors":"Ming Chen, Xinguang Huang, Dongyang Wang, Huizhuan Zhai, Mingjuan Sun, Hao Zhang, Haipeng Wang, Zengjun Li","doi":"10.1007/s12029-026-01458-2","DOIUrl":"https://doi.org/10.1007/s12029-026-01458-2","url":null,"abstract":"","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"57 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13102748/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147773539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Value of the Nutritional Risk Index and Hemoglobin-to-Platelet Ratio Score for Predicting Recurrence and Survival in Siewert II/III Gastroesophageal Junction Adenocarcinoma. 营养风险指数和血红蛋白血小板比评分预测Siewert II/III型胃食管交界处腺癌复发和生存的预后价值。
IF 1.6
Journal of Gastrointestinal Cancer Pub Date : 2026-04-21 DOI: 10.1007/s12029-026-01469-z
Dianhong Lian, Zhen Yuan, Hao Cui, Bo Cao, Qixuan Xu, Ruiyang Zhao, Zhiyuan Yu, Jiajun Du, Jinghang Wang, Huiguang Ren, Yuyuan Lu, Ruiyang Zhang, Jianxin Cui, Wenquan Liang, Bo Wei
{"title":"Prognostic Value of the Nutritional Risk Index and Hemoglobin-to-Platelet Ratio Score for Predicting Recurrence and Survival in Siewert II/III Gastroesophageal Junction Adenocarcinoma.","authors":"Dianhong Lian, Zhen Yuan, Hao Cui, Bo Cao, Qixuan Xu, Ruiyang Zhao, Zhiyuan Yu, Jiajun Du, Jinghang Wang, Huiguang Ren, Yuyuan Lu, Ruiyang Zhang, Jianxin Cui, Wenquan Liang, Bo Wei","doi":"10.1007/s12029-026-01469-z","DOIUrl":"https://doi.org/10.1007/s12029-026-01469-z","url":null,"abstract":"","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"57 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147729355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书